ANPC 0.00 AnPac Bio-Medical Science Co., Ltd.
| Range: | 2.6-11.99 | Vol Avg: | 22069 | Last Div: | 0 | Changes: | -0.14 |
| Beta: | 1.56 | Cap: | 0.03B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jan 30 2020 | Empoloyees: | 89 | ||
| CUSIP: | 03635R107 | CIK: | 0001786511 | ISIN: | US03635R2067 | Country: | CN |
| CEO: | Dr. Chris Chang Yu | Website: | https://www.anpacbio.com | ||||
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow